Identification of Novel Aberrant Methylation of BASP1 and SRD5A2 for Early Diagnosis of Hepatocellular Carcinoma by Genome-Wide Search

International Journal of Oncology - Greece
doi 10.3892/ijo_00000082
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Spandidos Publications

Related search

Genome-Wide DNA Methylation Analysis in Hepatocellular Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2016English

Clinical Significance of Aberrant DEUP1 Promoter Methylation in Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2019English

Screening and Early Diagnosis of Hepatocellular Carcinoma

ACTUAL INFECTOLOGY
2018English

Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma

American Journal of Pathology
Forensic MedicinePathology
2003English

Mechanistic and Prognostic Significance of Aberrant Methylation in the Molecular Pathogenesis of Human Hepatocellular Carcinoma

Journal of Clinical Investigation
Medicine
2007English

Current Limitations and Potential Breakthroughs for the Early Diagnosis of Hepatocellular Carcinoma

Gut and Liver
HepatologyGastroenterology
2011English

Aberrant Promoter Methylation Profiles and Association With Survival in Patients With Hepatocellular Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2017English

Identification of CELSR2 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Identification and Validation of Novel Long Non-Coding RNA Biomarkers for Early Diagnosis of Oral Squamous Cell Carcinoma

Frontiers in Bioengineering and Biotechnology
BioengineeringBiomedical EngineeringHistologyBiotechnology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy